Immunogenetic Predictors of Severe COVID-19

According to an analysis of published data, only 20% of patients with the new coronavirus infection develop severe life-threatening complications. Currently, there are no known biomarkers, the determination of which before the onset of the disease would allow assessing the likelihood of its severe c...

Descripción completa

Detalles Bibliográficos
Autores principales: Malkova, Anna, Kudlay, Dmitriy, Kudryavtsev, Igor, Starshinova, Anna, Yablonskiy, Piotr, Shoenfeld, Yehuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001669/
https://www.ncbi.nlm.nih.gov/pubmed/33802310
http://dx.doi.org/10.3390/vaccines9030211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001669/
https://www.ncbi.nlm.nih.gov/pubmed/33802310
http://dx.doi.org/10.3390/vaccines9030211

Ejemplares similares